The Lobbying Register, read carefully Epicycle

Returns

Every filed return on the register. Filter, then open any return on lobbying.ie to read it in full.

Clear all

Showing returns filed by Janssen Sciences Ireland UC .

Filed returns
123
match these filters
Matching filed returns per period 0 5 10 15 20 Jan–Apr 2017: 1 filed returns May–Aug 2017: 1 filed returns May–Aug 2018: 3 filed returns Sep–Dec 2018: 4 filed returns Jan–Apr 2019: 4 filed returns May–Aug 2019: 3 filed returns Sep–Dec 2019: 2 filed returns Jan–Apr 2020: 3 filed returns May–Aug 2020: 1 filed returns Sep–Dec 2020: 2 filed returns Jan–Apr 2021: 5 filed returns May–Aug 2021: 4 filed returns Sep–Dec 2021: 4 filed returns Jan–Apr 2022: 4 filed returns May–Aug 2022: 1 filed returns Sep–Dec 2022: 2 filed returns Jan–Apr 2023: 7 filed returns May–Aug 2023: 4 filed returns Sep–Dec 2023: 6 filed returns Jan–Apr 2024: 13 filed returns May–Aug 2024: 6 filed returns Sep–Dec 2024: 7 filed returns Jan–Apr 2025: 6 filed returns May–Aug 2025: 5 filed returns Sep–Dec 2025: 12 filed returns Jan–Apr 2026: 10 filed returns May–Aug 2026: 3 filed returns 2017 2019 2020 2021 2022 2023 2024 2025 2026
Filed returns per four-month period Click a column to list its returns.
PeriodRegistrantPolicy areaSubject, as filedOfficials namedLink
Sep–Dec 2020 Janssen Sciences Ireland UC Health Sharing information on access to new medicines for Irish patients and COVID-19 vaccine update (Public policy or programme) 2 On lobbying.ie
May–Aug 2020 Janssen Sciences Ireland UC Health Sharing information on backlog of approved cancer medicines and consequences for treatment of patients (Public policy or programme) 4 On lobbying.ie
Jan–Apr 2020 Janssen Sciences Ireland UC Health Sharing update on the timeline for the development of JnJ vaccine for COVID-19 and about some of JnJ’s local efforts to assist the health service during pandemic (Public policy or programme) 6 On lobbying.ie
Jan–Apr 2020 Janssen Sciences Ireland UC Economic Development and Industry Briefing on business continuity plans during COVID-19 pandemic and progress on vaccine development as well as offering to support health service with expertise and capabilities (Public policy or programme) 4 On lobbying.ie
Jan–Apr 2020 Janssen Sciences Ireland UC Health Sharing information on backlog of approved cancer medicines and consequences for treatment of patients (Public policy or programme) 9 On lobbying.ie
Sep–Dec 2019 Janssen Sciences Ireland UC Economic Development and Industry Meeting to discuss operations of J&J in Ireland; EU Digital Health agenda; initiatives increase female participation in STEM-related careers; and implications of Brexit (Public policy or programme) 1 On lobbying.ie
Sep–Dec 2019 Janssen Sciences Ireland UC Public Expenditure and Reform Site visit to Janssen Bio2 and discussed how State can continue to support and collaborate with life sciences sector (Public policy or programme) 1 On lobbying.ie
May–Aug 2019 Janssen Sciences Ireland UC Health Invite to visit Janssen garden ‘Grounded’ at Bloom in the Park festival (Public policy or programme) 6 On lobbying.ie
May–Aug 2019 Janssen Sciences Ireland UC Economic Development and Industry Sharing overview of life sciences industry and Johnson and Johnson activities in Ireland (Public policy or programme) 1 On lobbying.ie
May–Aug 2019 Janssen Sciences Ireland UC Health Sharing information on medicines budget trends and potential for new models of value assessment (Public policy or programme) 4 On lobbying.ie
Jan–Apr 2019 Janssen Sciences Ireland UC Economic Development and Industry Event Invite (Public policy or programme) 3 On lobbying.ie
Jan–Apr 2019 Janssen Sciences Ireland UC Health Outcomes based contracting for medicines (Public policy or programme) 5 On lobbying.ie
Jan–Apr 2019 Janssen Sciences Ireland UC Health Impact of Brexit on the Life Sciences Sector (Public policy or programme) 1 On lobbying.ie
Jan–Apr 2019 Janssen Sciences Ireland UC Health Access to Innovative Medicines (Public policy or programme) 1 On lobbying.ie
Sep–Dec 2018 Janssen Sciences Ireland UC Health Outcomes based contracting for medicines (Public policy or programme) 6 On lobbying.ie
Sep–Dec 2018 Janssen Sciences Ireland UC Education and Training Female Participation in STEM-Related Careers (Public policy or programme) 4 On lobbying.ie
Sep–Dec 2018 Janssen Sciences Ireland UC Economic Development and Industry Visit to JSI BIOCorK2 project site (Public policy or programme) 2 On lobbying.ie
Sep–Dec 2018 Janssen Sciences Ireland UC Economic Development and Industry Impact of Brexit on the Life Sciences Sector (Public policy or programme) 4 On lobbying.ie
May–Aug 2018 Janssen Sciences Ireland UC Health Neuroscience Disease Areas (Public policy or programme) 1 On lobbying.ie
May–Aug 2018 Janssen Sciences Ireland UC Health Health Technology Assessment Regulation (Legislation) 2 On lobbying.ie
May–Aug 2018 Janssen Sciences Ireland UC Economic Development and Industry Impact of Brexit (Public policy or programme) 1 On lobbying.ie
May–Aug 2017 Janssen Sciences Ireland UC Economic Development and Industry Companies (Accounting) Bill 2016 section 3(1)(j) (Legislation) 1 On lobbying.ie
Jan–Apr 2017 Janssen Sciences Ireland UC Economic Development and Industry Companies (Accounting) Bill 2016 section 3(1)(j) (Legislation) 3 On lobbying.ie

Policy areas in these returns

Public policy areaFiled returnsShareRelative to the largest
Health 58 47.2%
Economic Development and Industry 46 37.4%
EU Affairs 9 7.3%
Budgetary matters 4 3.3%
Justice and Equality 2 1.6%
Trade 2 1.6%
Education and Training 1 0.8%
Public Expenditure and Reform 1 0.8%